Table 2 Demographic and clinical characteristics of patients and controls enrolled for Ca2+ homeostasis study.
Controls | GA RR-MS patients | INF-β1b RR-MS patients | INF-β1a RR-MS patients | Drug naïve RR-MS patients | |
|---|---|---|---|---|---|
Total | 3 | 4 | 3 | 3 | 3 |
Age (years; mean ± SD) | 30 ± 7.0 | 33.25 ± 5.4 | 34.5 ± 1.1 | 35.5 ± 3.5 | 31.5 ± 3.5 |
Age at onset (years; mean ± SD) | 30.5 ± 7.4 | 26.5 ± 3.5 | 28 ± 6.5 | ||
DD (years; mean ± SD) | 8.75 ± 5.8 | 11.5 ± 3.7 | 9.5 ± 4.0 | ||
EDSS (mean ± SD) | 2.375 ± 1.0 | 2.25 ± 0.3 | 3.225 ± 0.2 | 2.5 ± 0 |
